Learn more

GT BIOPHARMA INC

Overview
  • Total Patents
    14
  • GoodIP Patent Rank
    118,747
  • Filing trend
    ⇧ 450.0%
About

GT BIOPHARMA INC has a total of 14 patent applications. It increased the IP activity by 450.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Taiwan and United States. Its main competitors in its focus markets pharmaceuticals are COUGAR BIOTECHNOLOGY INC, RIVOPHARM SA and REVEN IP HOLDCO LLC.

Patent filings in countries

World map showing GT BIOPHARMA INCs patent filings in countries
# Country Total Patents
#1 WIPO (World Intellectual Property Organization) 6
#2 Taiwan 5
#3 United States 2
#4 Canada 1

Patent filings per year

Chart showing GT BIOPHARMA INCs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals

Focus technologies

# Technology
#1 Medical preparations
#2 Therapeutic chemical compounds

Top inventors

# Name Total Patents
#1 Clarence-Smith Kathleen E 10
#2 Clarence-Smith Kathleen 4

Latest patents

Publication Filing date Title
WO2020014072A1 Neostigmine pharmaceutical combination for treating myasthenia gravis
TW201919597A Pharmaceutical compositions and methods utilizing NEOSTIGMINE and a NK1 antagonist for treating myasthenia gravis
WO2019023318A1 Pharmaceutical compositions and methods utilizing pyridostigmine and a nk-1 antagonist for treating myasthenia gravis
WO2019023175A1 Pharmaceutical compositions and methods utilizing neostigmine and a nk-1 antagonist for treating myasthenia gravis
US2020000756A1 Neostigmine combination and compositions
CA3071377A1 Use and composition for treating myasthenia gravis and other myasthenic syndromes
US2019365694A1 Composition of matter and use thereof for preventing and treating motion sickness